Financial institutions hunting for Symbiotics funding are approaching what the firm calls "the leading market access platform for impact investing, dedicated to private markets in emerging and frontier economies." Based in Switzerland, Symbiotics offers investment, asset management and capacity-building services, channelling private capital to micro, small and medium enterprises and low- and middle-income households across emerging and frontier markets. Its official numbers: an aggregate portfolio of USD 2.5 billion across 19 funds and mandates, and since 2005 more than 9,500 investments representing USD 12.1 billion for 670 companies in 99 countries.
Thesis and focus areas
Financial inclusion is the core impact theme, with selective allocations to climate, fintech and agriculture (via its Emerging Credit Fund). It invests through private debt (senior and subordinated), bond issuance and syndication platforms, and equity-style structured investments in financial institutions, corporates and projects.
Fund size and cheque size
Aggregate portfolio: USD 2.5 billion across 19 funds and mandates (official site). Individual deal sizes in recent announcements run from $5.5 million to $18 million of debt — institution-scale, not seed-stage.
Portfolio and track record
Recent investments from its own news page: Fido Ghana ($5.5M debt to boost AI-powered financial inclusion, Feb 2026), Beacon Power Services (energy efficiency in Africa, Feb 2026), Dugar Finance (India) ($18M to scale secured MSME lending, Jan 2026) and Banco Múltiple Ademi (Dominican Republic) ($16M for financial inclusion, Jan 2026).
People behind the firm
Daniel Schriber is CEO of Symbiotics Asset Management; Arushi Wanchoo Kaul is Senior Portfolio Manager for the Emerging Credit Fund; Samy Derradji heads corporate communication.
Programs
The flagship vehicle is the Emerging Credit Fund (ECF) — an SFDR Article 9 open-ended private debt fund structured as a Luxembourg SICAV (Part II), targeting financial inclusion with selective climate, fintech and agriculture allocations. Symbiotics also runs capacity building: 170+ technical assistance projects worth over USD 19 million for portfolio companies, and it is a Certified B Corp.
How to apply for funding from Symbiotics
The flagship vehicle is the Emerging Credit Fund (ECF) — an SFDR Article 9 open-ended private debt fund structured as a Luxembourg SICAV (Part II), targeting financial inclusion with selective climate, fintech and agriculture allocations. Symbiotics also runs capacity building: 170+ technical assistance projects worth over USD 19 million for portfolio companies, and it is a Certified B Corp. There is no dedicated public application route for investees on the official site — the platform routes institutional investors to its funds and mandates. Financial institutions should reach out via the contact page at symbioticsgroup.com with a crisp institutional profile.
Why it matters for founders
Symbiotics shows where impact capital really scales: $2.5 billion of private debt into 670 companies — this is how microfinance institutions and MSME lenders in emerging markets actually get funded. For Indian NBFCs and fintech lenders, the takeaway is that Symbiotics buys institutional-grade debt stories with measurable inclusion outcomes, not startup pitches. Come with audited books and portfolio data.